A Study of ATR-101 for the Treatment of Congenital Adrenal Hyperplasia

NCT02804178 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Congenital Adrenal Hyperplasia

Interventions

DRUG: ATR-101

Sponsor

Millendo Therapeutics, Inc.